Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARVINAS, INC. | Director | Common Stock | 10K | $471K | $47.05 | May 29, 2024 | Direct |
ARVINAS, INC. | Director | Stock Option (right to buy) | 9.07K | $145K | $16.00 | May 29, 2024 | Direct |
VBI Vaccines Inc/BC | Director | Option (Right to Buy Common Shares) | 75K | Jan 27, 2022 | Direct | ||
Codiak BioSciences, Inc. | Chief Financial Officer | Common Stock | 0 | Mar 28, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARVN | ARVINAS, INC. | May 29, 2024 | 2 | $0 | 4 | May 31, 2024 | Director |
ARVN | ARVINAS, INC. | Jun 15, 2023 | 2 | $0 | 4 | Jun 20, 2023 | Director |
CDAKQ | Codiak BioSciences, Inc. | Mar 28, 2023 | 1 | -$2.27K | 4 | Mar 30, 2023 | Chief Financial Officer |
CDAKQ | Codiak BioSciences, Inc. | Jan 24, 2023 | 1 | $0 | 4 | Jan 26, 2023 | Chief Financial Officer |
CDAKQ | Codiak BioSciences, Inc. | Jan 19, 2023 | 3 | -$1.08K | 4 | Jan 23, 2023 | Chief Financial Officer |
CDAKQ | Codiak BioSciences, Inc. | Sep 16, 2022 | 1 | $0 | 4 | Sep 20, 2022 | Chief Financial Officer |
CDAKQ | Codiak BioSciences, Inc. | Aug 16, 2022 | 6 | -$6.75K | 4 | Feb 21, 2023 | Chief Financial Officer |
ARVN | ARVINAS, INC. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
CDAKQ | Codiak BioSciences, Inc. | Feb 16, 2022 | 2 | $0 | 4 | Feb 18, 2022 | Chief Financial Officer |
VBIV | VBI Vaccines Inc/BC | Jan 27, 2022 | 1 | $0 | 4 | Jan 31, 2022 | Director |
CDAKQ | Codiak BioSciences, Inc. | Jan 19, 2022 | 2 | $0 | 4 | Jan 21, 2022 | Chief Financial Officer |
VBIV | VBI Vaccines Inc/BC | Jul 1, 2021 | 1 | $0 | 4 | Jul 7, 2021 | Director |
VBIV | VBI Vaccines Inc/BC | Jul 1, 2021 | 0 | $0 | 3 | Jul 7, 2021 | Director |
ARVN | ARVINAS, INC. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |